CAR-T Cell Therapy Shows Promising Results in Treating Autoimmune Diseases
A 47-year-old woman with three life-threatening autoimmune diseases has experienced a significant recovery after undergoing CAR-T cell therapy at University Hospital Erlangen in Germany. The patient, who had been living with autoimmune haemolytic anaemia (AIHA), immune thrombocytopenia (ITP), and antiphospholipid syndrome (APS), had previously undergone nine different treatments without lasting success. The CAR-T cell therapy involved reengineering her T-cells to target and destroy problematic B-cells, which were responsible for her conditions. Within weeks of the treatment, all three diseases showed a marked improvement, allowing the woman to enter a treatment-free remission for the past 14 months. This case marks a world first in the application of CAR-T cell therapy for autoimmune diseases, traditionally used in cancer treatment. 
